Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 6 minute read Pharma Industry News Technology News Applied DNA Sciences makes bold crypto-biotech crossover with $17m BNB treasury and $58m funding Find out how Applied DNA Sciences is redefining biotech strategy through a $17 million BNB treasury and $58 million private placement plan. bySoujanya RaviOctober 22, 2025